Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, announced that the first patient has been ...
The trial is designed to evaluate AUTX-703’s tolerability, pharmacodynamics, safety, preliminary clinical activity, and pharmacokinetics. Credit: Freedomz/Shutterstock. Auron Therapeutics has dosed ...
NEWTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory ...
The Magic: The Gathering – Final Fantasy crossover launches June 13, 2025, with pre-releases starting June 6, 2025. The set will include Play Boosters, Commander Decks, and Collector Boosters ...
NEWTON, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Auron Therapeutics has raised a $27 million Series B ...
NEWTON, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Auron Therapeutics has raised a ...
Auron MacIntyre is the host of a popular podcast on BlazeTV, on which he interviews guests, most—but not all—of whom share his “organic conservative” perspective. He often has valuable things to say, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results